Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-22T08:09:26.708Z Has data issue: false hasContentIssue false
  • English
  • Français

Antiparkinsonian Drugs and Depot Neuroleptics

Published online by Cambridge University Press:  29 January 2018

R. H. S. Mindham
R. H. S. Mindham*
Affiliation:
The Johns Hopkins Hospital, The Henry Phipps Psychiatric Clinic, 600 N. Wolfe Street, Baltimore, Maryland 21205
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 141 , Issue 2 , August 1982 , pp. 211 - 212
Copyright
Copyright © Royal College of Psychiatrists, 1982 

References

Bennie, E. H. (1982) Anti-parkinsonian medication in depressed schizophrenics on depot neuroleptics. British Journal of Psychiatry, 140, 210.Google Scholar
Kiloh, L. G., Smith, S. J. & Williams, S. E. (1973) Anti-parkinson drugs as causal agents in tardive dyskinesias. Medical Journal of Australia, 2, 591–3.Google Scholar
Klawans, H. L. (1973) The pharmacology of tardive dyskinesias. American Journal of Psychiatry, 130, 82–6.Google Scholar
Manos, N., Gkiouzepas, J. & Logothetis, J. (1981) The need for continuous use of anti-parkinson medication with chronic schizophrenic patients receiving long-term neuroleptic therapy. American Journal of Psychiatry, 138, 184–8.Google Scholar
Marsden, C. D., Mindham, R. H. S. & MacKay, A. V. P. (1982) Drug-induced extrapyramidal syndromes. In The Psychopharmacology of Schizophrenia, (eds. Hirsch, S. R. and Bradley, P.). Oxford, University Press. In press.Google Scholar
Mindham, R. H. S., Gaind, R., Anstee, B. H. & Rimmer, L. (1972) Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Psychological Medicine, 2, 406–13.Google Scholar
Mindham, R. H. S. (1976) The assessment of drug-induced extrapyramidal reactions and of drugs given for their control. British Journal of Clinical Pharmacology, 3, 395–400.CrossRefGoogle ScholarPubMed
Onuaguluchi, G. (1964) Parkinsonism, p 125. London: Butterworths Google Scholar
Rivera-Calimlim, L., Castaneda, L. & Lasagna, L. (1973) Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clinical Pharmacology and Therapeutics, 14, 978–86.Google Scholar
Singh, M. M. & Kay, S. R. (1975) Therapeutic reversal with benztropine in schizophrenics—practical and theoretical significance. Journal of Nervous and Mental Disease, 169, 258–66.Google Scholar
Westlake, R. J. & Rastegar, A. (1973) Hyperpyrexia from drug combinations. Journal of the American Medical Association, 225, 1250.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.